Global Electrical Ablators Market Research Report
- Report Code: EL 1000
- Publish Date: Upcoming
The global electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery. The market was valued $785 million in 2013 and is expected to reach $1,006 million by 2018.
Tachycardia and atrial arrhythmia occur in people where cardiac electrical impulses move abnormally through a deviated path involving extra tissue. This impulse creates an abnormal pattern of elevated or decreased heartbeats in a patient. Electrical ablators are used for such conditions and ablate healthy cells so as to cut off electrical impulses that are causing the uneven heartbeats. The procedure can be done percutaneously or by minimally invasive techniques using ultrasound imaging, fluoroscopy, or MRI.
The report "Global Electrical Ablators Market Forecast, 2010-2018", analyzes the market of devices under two segments such as argon plasma/beam coagulator and irreversible electroporation. The high success rate (above 70%) for removal of arrhythmic heart conditions is the major factor that is driving this market. There are over 14 million arrhythmia cases with fatality rates of 15% annually. It affects over 10% of the population over the age of 80 globally. This rate of increase in heart conditions is predicted to sustain the electrical ablation technology market through 2016, at a CAGR of 5.20%.
Americas will continue to be a big market for electrical ablator devices and will continue to offer opportunities in future as established market players consider can and cardiovascular diseases as the top application ares. As the patient population will increase it will lead to an increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for electrical ablators.
Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive ablation devices is emerging as an important factor. It has provided an opportunity for electrical ablator companies to have an established and growing market in these countries. The aging population in Japan, which is at a higher risk of developing chronic diseases such as cancer and cardiac disorders, will ultimately cause the growth in procedure volume in the future.
The European market is challenging as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Recent trends show an increased inclination of companies towards Europe for the development and launch of their preliminary products. In addition, it is observed that capital investment required for regulatory approval of a product is significantly less than that compared to the U.S. Ultimately, market players are adopting a strategy to launch their products initially in Europe, as it offers an opportunity to balance the risk-to-reward ratio in case of innovative technologies.
Traditional electric ablation probes are not effective for ablating certain tissue types such as adhesions which develop in a large fraction of patients after surgery. Thus, there is an unmet need for devices that are suitable for ablating a variety of abnormal tissues, adhesions, and fibrous growths. Minimally invasive surgical devices are yet another area of expansion for market players in the ablation technologies market.
The report provides an extensive competitive landscape of companies operating in the electrical ablator market. The key players of the market covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report.
Customization Options
Along with market data, you can also customize MMM that are in keeping with your company’s specific needs. Customize your report on the global electrical ablator market to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence and patient pool of cancer, cardiovascular disorders, gynecological and orthopedic disorders
- Disease progression (pattern analysis)
Surgeon/Physician Perception Analysis
- Fast turnaround analysis of surgeons’ response to market events and trends
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Argon Plasma/Beam coagulators Argon Plasma/Beam coagulators and Irreversible electroporation adds up to total |
Upcoming |
|
|
Irreversible electroporation Irreversible electroporation and Argon Plasma/Beam coagulators adds up to total |
Upcoming |
|
|
Americas Electrical Ablators The electrical ablation market of the Americas, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $387 million in 2013 and is expected to reach $480 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Asia-Pacific Electrical Ablators The Asia-Pacific electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $159 million in 2013 and is expected to reach $236 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
European Electrical Ablators The European electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $189 million in 2013 and is expected to reach $228 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
